Sectoral Asset Management as of March 31, 2016
Portfolio Holdings for Sectoral Asset Management
Sectoral Asset Management holds 81 positions in its portfolio as reported in the March 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Celgene Corporation | 7.2 | $150M | 1.5M | 100.09 | |
| Gilead Sciences (GILD) | 7.2 | $149M | 1.6M | 91.86 | |
| BioMarin Pharmaceutical (BMRN) | 5.9 | $123M | 1.5M | 82.48 | |
| Amgen (AMGN) | 5.0 | $102M | 683k | 149.93 | |
| Alexion Pharmaceuticals | 4.4 | $92M | 657k | 139.22 | |
| Regeneron Pharmaceuticals (REGN) | 4.1 | $84M | 233k | 360.44 | |
| Incyte Corporation (INCY) | 4.0 | $84M | 1.2M | 72.47 | |
| Amicus Therapeutics (FOLD) | 3.8 | $78M | 9.2M | 8.45 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 3.5 | $71M | 897k | 79.49 | |
| Shire | 3.4 | $70M | 405k | 171.90 | |
| Neurocrine Biosciences (NBIX) | 3.2 | $65M | 1.6M | 39.55 | |
| Biogen Idec (BIIB) | 3.0 | $61M | 235k | 260.32 | |
| Thermo Fisher Scientific (TMO) | 2.5 | $52M | 370k | 141.59 | |
| Merck & Co (MRK) | 1.9 | $40M | 750k | 52.91 | |
| Dex (DXCM) | 1.9 | $39M | 572k | 67.91 | |
| Acceleron Pharma | 1.8 | $38M | 1.4M | 26.39 | |
| Eli Lilly & Co. (LLY) | 1.8 | $37M | 507k | 72.01 | |
| Medtronic (MDT) | 1.7 | $36M | 476k | 75.00 | |
| Portola Pharmaceuticals | 1.6 | $33M | 1.6M | 20.40 | |
| Alder Biopharmaceuticals | 1.5 | $32M | 1.3M | 24.49 | |
| Intercept Pharmaceuticals In | 1.5 | $32M | 245k | 128.47 | |
| Align Technology (ALGN) | 1.5 | $31M | 423k | 72.69 | |
| Tesaro | 1.5 | $30M | 690k | 44.03 | |
| Teva Pharmaceutical Industries (TEVA) | 1.3 | $27M | 509k | 53.51 | |
| Mylan Nv | 1.3 | $27M | 590k | 46.35 | |
| NxStage Medical | 1.2 | $25M | 1.6M | 14.99 | |
| Adeptus Health Inc-class A | 1.2 | $25M | 445k | 55.54 | |
| Acadia Healthcare (ACHC) | 1.1 | $23M | 419k | 55.11 | |
| UnitedHealth (UNH) | 1.1 | $23M | 176k | 128.90 | |
| Advaxis | 0.9 | $20M | 2.2M | 9.03 | |
| ACADIA Pharmaceuticals (ACAD) | 0.9 | $19M | 691k | 27.96 | |
| St. Jude Medical | 0.9 | $18M | 335k | 55.00 | |
| Sagent Pharmaceuticals | 0.9 | $18M | 1.5M | 12.17 | |
| Ionis Pharmaceuticals (IONS) | 0.8 | $18M | 433k | 40.50 | |
| Uniqure Nv (QURE) | 0.8 | $17M | 1.4M | 11.88 | |
| Ptc Therapeutics I (PTCT) | 0.8 | $17M | 2.6M | 6.44 | |
| Prothena (PRTA) | 0.8 | $16M | 398k | 41.16 | |
| Ophthotech | 0.7 | $15M | 357k | 42.27 | |
| Intuitive Surgical (ISRG) | 0.7 | $14M | 23k | 601.06 | |
| Sage Therapeutics (SAGE) | 0.7 | $14M | 421k | 32.06 | |
| Aimmune Therapeutics | 0.6 | $13M | 982k | 13.56 | |
| Tg Therapeutics (TGTX) | 0.6 | $13M | 1.5M | 8.52 | |
| Novo Nordisk A/S (NVO) | 0.6 | $12M | 216k | 54.19 | |
| Team Health Holdings | 0.5 | $11M | 269k | 41.81 | |
| Immune Design | 0.5 | $11M | 857k | 13.00 | |
| Edwards Lifesciences (EW) | 0.5 | $9.8M | 111k | 88.21 | |
| Teladoc (TDOC) | 0.5 | $9.4M | 976k | 9.60 | |
| Novartis (NVS) | 0.4 | $9.0M | 124k | 72.44 | |
| NuVasive | 0.4 | $8.1M | 166k | 48.65 | |
| Avexis | 0.4 | $8.1M | 298k | 27.24 | |
| Pronai Therapeutics | 0.4 | $7.7M | 1.1M | 6.74 | |
| Cara Therapeutics (CARA) | 0.4 | $7.5M | 1.2M | 6.22 | |
| Regenxbio Inc equity us cm (RGNX) | 0.4 | $7.3M | 680k | 10.80 | |
| AmSurg | 0.3 | $7.2M | 96k | 74.60 | |
| Momenta Pharmaceuticals | 0.3 | $6.3M | 681k | 9.24 | |
| Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 0.3 | $5.3M | 294k | 18.15 | |
| Abiomed | 0.2 | $5.1M | 54k | 94.81 | |
| Molina Healthcare (MOH) | 0.2 | $5.2M | 81k | 64.49 | |
| Accuray Incorporated (ARAY) | 0.2 | $4.5M | 772k | 5.78 | |
| Dr. Reddy's Laboratories (RDY) | 0.2 | $4.2M | 92k | 45.19 | |
| Integra LifeSciences Holdings (IART) | 0.2 | $4.1M | 61k | 67.35 | |
| Pra Health Sciences | 0.2 | $4.2M | 98k | 42.76 | |
| Surgical Care Affiliates | 0.2 | $3.7M | 79k | 46.28 | |
| Wright Medical Group Nv | 0.1 | $3.0M | 182k | 16.60 | |
| Allergan | 0.1 | $2.8M | 11k | 267.99 | |
| Entellus Medical Cm | 0.1 | $2.7M | 150k | 18.19 | |
| Anacor Pharmaceuticals In | 0.1 | $2.5M | 47k | 53.44 | |
| Lannett Company | 0.1 | $2.3M | 130k | 17.93 | |
| Perrigo Company (PRGO) | 0.1 | $2.2M | 17k | 127.95 | |
| Tandem Diabetes Care | 0.1 | $2.3M | 269k | 8.71 | |
| Intersect Ent | 0.1 | $2.2M | 116k | 19.00 | |
| Novavax | 0.1 | $2.1M | 413k | 5.16 | |
| Mallinckrodt Pub | 0.1 | $1.7M | 28k | 61.27 | |
| Pronai Therapeutics | 0.1 | $1.4M | 202k | 6.74 | |
| Akorn | 0.0 | $794k | 34k | 23.53 | |
| Profound Medical | 0.0 | $918k | 1.0M | 0.89 | |
| China Biologic Products | 0.0 | $674k | 5.9k | 114.43 | |
| Ascendis Pharma A S (ASND) | 0.0 | $577k | 31k | 18.55 | |
| Amphastar Pharmaceuticals (AMPH) | 0.0 | $467k | 39k | 12.00 | |
| Nektar Therapeutics (NKTR) | 0.0 | $175k | 13k | 13.71 | |
| Ironwood Pharmaceuticals (IRWD) | 0.0 | $117k | 11k | 10.91 |
